228 related articles for article (PubMed ID: 19646420)
1. PTP inhibitor IV protects JNK kinase activity by inhibiting dual-specificity phosphatase 14 (DUSP14).
Park JE; Park BC; Song M; Park SG; Lee DH; Park SY; Kim JH; Cho S
Biochem Biophys Res Commun; 2009 Oct; 387(4):795-9. PubMed ID: 19646420
[TBL] [Abstract][Full Text] [Related]
2. NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26).
Song M; Park JE; Park SG; Lee DH; Choi HK; Park BC; Ryu SE; Kim JH; Cho S
Biochem Biophys Res Commun; 2009 Apr; 381(4):491-5. PubMed ID: 19233143
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of dual-specificity phosphatase 26 by ethyl-3,4-dephostatin: Ethyl-3,4-dephostatin as a multiphosphatase inhibitor.
Seo H; Cho S
Pharmazie; 2016 Apr; 71(4):196-200. PubMed ID: 27209699
[TBL] [Abstract][Full Text] [Related]
4. A one-step method to identify MAP kinase residues involved in inactivation by tyrosine- and dual-specificity protein phosphatases.
Tárrega C; Pulido R
Anal Biochem; 2009 Nov; 394(1):81-6. PubMed ID: 19583964
[TBL] [Abstract][Full Text] [Related]
5. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation.
Yang CY; Li JP; Chiu LL; Lan JL; Chen DY; Chuang HC; Huang CY; Tan TH
J Immunol; 2014 Feb; 192(4):1547-57. PubMed ID: 24403530
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
Chen L; Sung SS; Yip ML; Lawrence HR; Ren Y; Guida WC; Sebti SM; Lawrence NJ; Wu J
Mol Pharmacol; 2006 Aug; 70(2):562-70. PubMed ID: 16717135
[TBL] [Abstract][Full Text] [Related]
7. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
[TBL] [Abstract][Full Text] [Related]
8. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
[TBL] [Abstract][Full Text] [Related]
9. TRAF2-mediated Lys63-linked ubiquitination of DUSP14/MKP6 is essential for its phosphatase activity.
Yang CY; Chiu LL; Tan TH
Cell Signal; 2016 Jan; 28(1):145-51. PubMed ID: 26521044
[TBL] [Abstract][Full Text] [Related]
10. Ginkgolic acid as a dual-targeting inhibitor for protein tyrosine phosphatases relevant to insulin resistance.
Yoon SY; Lee JH; Kwon SJ; Kang HJ; Chung SJ
Bioorg Chem; 2018 Dec; 81():264-269. PubMed ID: 30153591
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?
Shillingford SR; Bennett AM
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():617-636. PubMed ID: 36662585
[TBL] [Abstract][Full Text] [Related]
12. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
[TBL] [Abstract][Full Text] [Related]
13. Rhodanine derivatives as inhibitors of JSP-1.
Cutshall NS; O'Day C; Prezhdo M
Bioorg Med Chem Lett; 2005 Jul; 15(14):3374-9. PubMed ID: 15961311
[TBL] [Abstract][Full Text] [Related]
14. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
Bishop AC; Zhang XY; Lone AM
Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine kinase inhibitors block the stimulatory actions of phosphotyrosine phosphatase inhibitors to increase cell proliferation, alkaline phosphatase activity, and collagen synthesis in normal human bone cells.
Yoon HK; Baylink DJ; Lau KH
Am J Nephrol; 2000; 20(2):153-62. PubMed ID: 10773618
[TBL] [Abstract][Full Text] [Related]
16. Novel function of DUSP14/MKP6 (dual specific phosphatase 14) as a nonspecific regulatory molecule for delayed-type hypersensitivity.
Nakano Y
Br J Dermatol; 2007 May; 156(5):848-60. PubMed ID: 17263825
[TBL] [Abstract][Full Text] [Related]
17. Low M(r) protein tyrosine phosphatase inhibits growth and migration of vascular smooth muscle cells induced by platelet-derived growth factor.
Shimizu H; Shiota M; Yamada N; Miyazaki K; Ishida N; Kim S; Miyazaki H
Biochem Biophys Res Commun; 2001 Nov; 289(2):602-7. PubMed ID: 11716518
[TBL] [Abstract][Full Text] [Related]
18. Direct suppression of TCR-mediated activation of extracellular signal-regulated kinase by leukocyte protein tyrosine phosphatase, a tyrosine-specific phosphatase.
Oh-hora M; Ogata M; Mori Y; Adachi M; Imai K; Kosugi A; Hamaoka T
J Immunol; 1999 Aug; 163(3):1282-8. PubMed ID: 10415025
[TBL] [Abstract][Full Text] [Related]
19. K vitamins, PTP antagonism, and cell growth arrest.
Carr BI; Wang Z; Kar S
J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979
[TBL] [Abstract][Full Text] [Related]
20. Identification of a benzo imidazole thiazole derivative as the specific irreversible inhibitor of protein tyrosine phosphatase.
Ge L; Li KS; Li MM; Xiao P; Hou XB; Chen X; Liu HD; Lin A; Yu X; Ren GJ; Fang H; Sun JP
Bioorg Med Chem Lett; 2016 Oct; 26(19):4795-4798. PubMed ID: 27554446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
